Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 1

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 1
---
 (ii) each option to purchase Profusa Common Stock shall be converted into an option to purchase New Profusa Common Stock at the Exchange Ratio, and (iii) each warrant to purchase Profusa Common Stock shall be converted into a warrant to purchase New Profusa Common Stock at the Warrant Ratio (as defined in the Merger Agreement). Following the entry into Amendment No. 4 to the Merger Agreement (as defined above), the aggregate consideration to be received by the Profusa shareholders is based on the sum of (a) the pre -transactionequity value of $155,000,000, plus (b) the Incentive Equity Value (which is expected to be $29,018,330 for purposes of this proxy statement/prospectus), plus (c) the Private Placement Value (which is expected to be $14,867,899 for purposes of this proxy statement/prospectus), plus (d) the Aggregate Exercise Price, minus (e) the Aggregate Company Incentive Amount, and the Exchange Ratio will be equal to the value of a share of Profusa Common Stock, based on an equity valuation of Profusa of $155,000,000 (as adjusted for the Incentive Equity Value and the Private Placement Value), divided by an assumed value of New Profusa Common Stock of $10.00 per share. As of May8, 2025, the Exchange Ratio and the Company Reference Share Value are estimated to be 0.75 and $7.47, respectively, at the time of Closing. It is expected that, if the Business Combination is consummated, NorthView Common Stock and warrants would be listed on Nasdaq. In connection with the merger contemplated in the Merger Agreement, NorthView will change its name to Profusa, Inc., which is hereinafter referred to as “New Profusa.” Concurrently with the execution of the Merger Agreement, NorthView, Profusa, and our sponsor (the “Sponsor”) entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”) pursuant to which the Sponsor agreed to, among other things, (i) vote at any meeting of the stockholders of NorthView all of its shares of NorthView Common Stock in favor of the proposals relating to the Business Combination, (ii) not redeem any of its shares of NorthView Common Stock in connection with the Business Combination, (iii) be bound by certain other covenants and agreements related to the Business Combination, and (iv) be bound by certain